← Open Payments lookup

SANDRA CAYLER: Open Payments

NPI 1003466921 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$366 in 17 payments from 11 companies in 2025. Trend: 2023 $104 · 2024 $205 · 2025 $366

Food & beverage: $366
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.3$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Takeda Pharmaceuticals U.S.A., Inc.2$37
Otsuka America Pharmaceutical, Inc.2$37
Axsome Therapeutics, Inc.2$35
Janssen Pharmaceuticals, Inc1$26
IDORSIA PHARMACEUTICALS US INC1$22
Neos Therapeutics, LP1$20
Tris Pharma Inc1$20
Almatica Pharma LLC1$19

Products named: FANAPT, CAPLYTA, TRINTELLIX, REXULTI, Auvelity, HETLIOZ, SPRAVATO, Quviviq.

Industry payments across NE — which companies pay providers there.